Asensus Surgical Inc. buy krebskrebs
Start price
17.05.21
/
50%
€1.42
Target price
17.05.22
€2.00
Performance (%)
-73.34%
End price
18.05.22
€0.38
Summary
This prediction ended on 18.05.22 with a price of €0.38. The BUY prediction by krebskrebs for Asensus Surgical Inc. performed very badly with a performance of -73.34%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Asensus Surgical Inc. | - | - | - | - |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by krebskrebs for this prediction
In the thread Transenterix Inc diskutieren
Buy mit Kursziel 2,0
In the thread Trading Transenterix Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

